Intravenous Infusion of Esketamine in Combination With Pregabalin and Duloxetine for Postherpetic Neuralgia

Phase: NA | Sponsor: Beijing Tiantan Hospital | Compound: Ketamine

Status

recruiting

Institution

Beijing Tiantan Hospital

Start date

2025-04-01

End date

2026-05-01

Registry ID

NCT06896994

View trial record

Tracked by the DMT Code Clinical Trials Observatory, an open record of DMT-related clinical research.